Role of Dendritic Cells in Immunity to Pulmonary Influenza Virus Infections
树突状细胞在肺部流感病毒感染免疫中的作用
基本信息
- 批准号:8043531
- 负责人:
- 金额:$ 34.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-15 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AirAntigensApoptosisB-LymphocytesCellsCellular ImmunityCessation of lifeDendritic CellsDependenceDevelopmentDisease OutbreaksDoseEnvironmentEpidemicGoalsHumanImmune responseImmunityIn SituInfectionInfluenzaInterleukin-12LabelLinkLungLymphopeniaMediatingMethodsMusNatureOrgan Culture TechniquesOutcomePhenotypePositioning AttributePublic HealthRegulationResearchRespiratory MucosaRespiratory SystemRespiratory tract structureRoleSamplingShapesT cell responseT-Cell ActivationT-LymphocyteVaccinationVirulenceVirulentVirusVirus Diseasesadaptive immunityanti-influenzacell killingexpectationinfluenza epidemicinfluenzavirusinnovationinsightinterleukin-12 subunit p40lymph nodesmicroorganismmouse modelnovelpandemic diseasepandemic influenzapathogenreconstitutionrespiratoryresponsetool developmentvaccine development
项目摘要
DESCRIPTION (provided by applicant): The respiratory tract serves as a significant entry point for pathogens including many potential bioweapons. Among these pathogens, Influenza virus represents a serious public health threat not only with regard to epidemic influenza but also because of the increasing threat of pandemic outbreaks. Previous studies have shown that protection from lethal influenza virus infections is mediated in part by CDS T cell killing of influenza-infected cells. The induction, magnitude, and effector phenotype of this T cell response in turn is generally thought to be intimately linked to the dendritic cell (DC) response to virus challenge. However our current understanding of how DC specifically regulate respiratory T cell responses in general and responses to lethal (highly virulent) and sub-lethal influenza virus infections in particular is quite limited. Therefore our long-term goal is to understand the mechanisms through which DC regulate, dependent upon the nature of the pulmonary challenge, the CDS T cell response to pulmonary infections. Through such regulation, DC appear to ultimately determine the outcome of virulent influenza virus infections as our preliminary results show that influenza-specific CDS T cell responses are inhibited during lethal dose influenza virus infections. This inhibition is dependent upon FasL expression by lymph node DC (LNDC) and LNDC driven apoptosis of the developing T cell response. Therefore in this proposal we will continue to utilize our mouse model of influenza virus infection to determine how DC regulate influenza-specific CDS T cells responses following lethal and sublethal influenza virus infections in the following Specific Aims: 1) Determine which LNDC subset(s) mediate LNDC elimination of virus-specific CDS T cell responses following lethal influenza virus infections and if this elimination is antigen-specific 2) Determine the mechanisms regulating IL-12p40 dependent LNDC FasL expression 3) Determine the role of DC in the initiation of virus-specific CDS effector responses during lethal and sublethal influenza infections. This proposal will elucidate how DC regulate and control the influenza-specific CDS T cell response during lethal and sublethal influenza virus infections. Furthermore it will yield important insights into the DC regulatory mechanisms that will need to be inhibited during vaccinations and treatments aimed at enhancing protective pulmonary immunity, particularly during lethal influenza virus infections and vaccinations.
描述(由申请人提供):呼吸道是病原体(包括许多潜在的生物武器)的重要入口。在这些病原体中,流感病毒不仅就流行性流感而言,而且还因为大流行性爆发的日益增加的威胁而代表严重的公共卫生威胁。先前的研究表明,对致命流感病毒感染的保护部分是由CDS T细胞杀死流感感染的细胞介导的。这种T细胞应答的诱导、幅度和效应表型又通常被认为与树突状细胞(DC)对病毒攻击的应答密切相关。然而,我们目前对DC如何特异性地调节呼吸道T细胞反应以及对致死(高毒性)和亚致死流感病毒感染的反应的理解是非常有限的。因此,我们的长期目标是了解DC调节CDS T细胞对肺部感染的反应的机制,这取决于肺部挑战的性质。通过这种调节,DC似乎最终决定了强毒流感病毒感染的结果,因为我们的初步结果表明,在致死剂量流感病毒感染期间,流感特异性CDS T细胞应答被抑制。这种抑制依赖于淋巴结DC(LNDC)的FasL表达和LNDC驱动的发展中T细胞应答的凋亡。因此,在本提案中,我们将继续利用我们的流感病毒感染小鼠模型来确定DC如何在致死和亚致死流感病毒感染后调节流感特异性CDS T细胞应答,具体目的如下:1)确定在致死性流感病毒感染后哪个或哪些LNDC子集介导病毒特异性CDS T细胞应答的LNDC消除,以及这种消除是否是抗原特异性的确定调节IL-12 p40依赖性LNDC FasL表达的机制3)确定DC在致死和亚致死流感感染期间启动病毒特异性CDS效应子应答中的作用。该提案将阐明在致死和亚致死流感病毒感染期间DC如何调节和控制流感特异性CDS T细胞应答。此外,它将产生对DC调节机制的重要见解,这些调节机制在旨在增强保护性肺免疫的疫苗接种和治疗期间需要被抑制,特别是在致命的流感病毒感染和疫苗接种期间。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
- DOI:10.4049/jimmunol.0902984
- 发表时间:2010-04-15
- 期刊:
- 影响因子:0
- 作者:Langlois RA;Legge KL
- 通讯作者:Legge KL
Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs.
- DOI:10.1084/jem.20080314
- 发表时间:2008-07-07
- 期刊:
- 影响因子:0
- 作者:McGill J;Van Rooijen N;Legge KL
- 通讯作者:Legge KL
Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses.
- DOI:10.1371/journal.pone.0040733
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Boyden AW;Legge KL;Waldschmidt TJ
- 通讯作者:Waldschmidt TJ
IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection.
- DOI:10.1084/jem.20091711
- 发表时间:2010-03-15
- 期刊:
- 影响因子:0
- 作者:McGill J;Van Rooijen N;Legge KL
- 通讯作者:Legge KL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin L Legge其他文献
Kevin L Legge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin L Legge', 18)}}的其他基金
Protection and Immunity after Polyanhydride Nanoparticle Vaccination against Avian Influenza A Virus
聚酐纳米粒子疫苗接种甲型禽流感病毒后的保护和免疫作用
- 批准号:
10584130 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
Nanovaccine-Mediated Immune Protection Against Influenza Virus
纳米疫苗介导的流感病毒免疫保护
- 批准号:
10172830 - 财政年份:2017
- 资助金额:
$ 34.93万 - 项目类别:
Nanovaccine-Mediated Immune Protection Against Influenza Virus
纳米疫苗介导的流感病毒免疫保护
- 批准号:
9383422 - 财政年份:2017
- 资助金额:
$ 34.93万 - 项目类别:
Chronic Alcohol Alteration of Influenza-Specific CD8 T cell Immunity and Protection
慢性酒精改变流感特异性 CD8 T 细胞免疫和保护
- 批准号:
9090516 - 财政年份:2016
- 资助金额:
$ 34.93万 - 项目类别:
Chronic Alcohol Alteration of Influenza-Specific CD8 T cell Immunity and Protection
慢性酒精改变流感特异性 CD8 T 细胞免疫和保护
- 批准号:
9269492 - 财政年份:2016
- 资助金额:
$ 34.93万 - 项目类别:
Chronic Ethanol Consumption and Pulmonary Immune Suppression
慢性乙醇消耗与肺部免疫抑制
- 批准号:
8510043 - 财政年份:2013
- 资助金额:
$ 34.93万 - 项目类别:
Chronic Ethanol Consumption and Pulmonary Immune Suppression
慢性乙醇消耗与肺部免疫抑制
- 批准号:
8729464 - 财政年份:2013
- 资助金额:
$ 34.93万 - 项目类别:
Role of TRAIL in immunity to influenza virus infections
TRAIL 在流感病毒感染免疫中的作用
- 批准号:
7303699 - 财政年份:2007
- 资助金额:
$ 34.93万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别: